Low circulating levels of gastrin-17 in patients with Barrett's esophagus

World Journal of Gastroenterology

Volumn 11, Issue 38, 2005, Pages 5988-5992

  Sipponen, Pentti ^a   Vauhkonen, Matti ^a   Helske, Timo ^a   Kääriäinen, Ilpo ^a   Härkönen, Matti ^b  

^a JORVI HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Atrophic gastritis; Barrett's esophagus; Chronic gastritis; Diagnostics; Gastrin 17

Indexed keywords

GASTRIN 17; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CONTROLLED STUDY; DIET RESTRICTION; DYSPEPSIA; ELECTROIMMUNOASSAY; ENDOSCOPIC BIOPSY; FEMALE; FINLAND; GASTRITIS; GASTROSCOPY; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; INTESTINE EPITHELIUM; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PREDICTION; PREVALENCE; STOMACH MUCOSA;

EID: 28644437785     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i38.5988     Document Type: Article

References (25)

1. Hirschowitz BI, Molina E. Relation of gastric acid and pepsin secretion to gastrin levels in dogs given bombesin and gastrin-17. Am J Physiol 1983; 244: G546-551
2. Muller J, Kirchner T, Muller-Hermelink HK. Gastric endocrine cell hyperplasia and carcinoid tumors in atrophic gastritis type A. Am J Surg Pathol 1987; 11: 909-917
3. Malmström J, Stadil F. Gastrin content and gastrin release. Studies on the antral content of gastrin and its release to serum during stimulation by food. Scand J Gastroenterol 1976; 37: 71-76
4. Petersen B, Andersen BN. Increased concentrations of the NH2-terminal fragment of gastrin-17 in acute duodenal ulcer and acute gastritis. Scand J Gastroenterol 1983; 18: 635-641
5. Stepan V, Sugano K, Yamada T, Paerk J, Dickson CJ. Gastrin biosynthesis in canine G cells. Am J Physiol Gastrointest Liver Physiol 2002; 282: 766-775
6. Spechler SJ. Barrett's esophagus and esophageal adenocarcinoma: pathogenesis, diagnosis, and therapy. Med Clin North Am 2002; 86: 1423-1445
7. Fitzgerald RC. Significance of acid exposure in Barrett's esophagus. Am J Gastroenterol 2003; 98: 699-700
8. Falk GW. Barrett's esophagus. Gastroenterology 2002; 122: 1569-1591
9. Zaninotto G, Portale G, Parenti A, Lanza C, Costantini M, Molena D, Ruol A, Battaglia G, Costantino M, Epifani M, Nicoletti L. Role of acid and bile reflux in development of specialized metaplasia in distal oesophagus. Dig Liver Dis 2002; 34: 251-257
10. Cameron AJ. Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am 1997; 26: 487-494
11. Romero Y, Cameron AJ, Schaid DJ, McDonnell SK, Burgart LJ, Hardtke CL, Murray JA, Locke GR 3rd. Barrett's esophagus: prevalence in symptomatic relatives. Am J Gastroenterol 2002; 97: 1127-1132
12. Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002; 123: 636-639
13. Bersentes K, Fass R, Padda S, Johnson C, Sampliner RE. Prevalence of Barrett's esophagus in Hispanics is similar to Caucasians. Dig Dis Sci 1998; 43: 1038-1041
14. Spechler SJ. Columnar-lined epithelium. Definitions. Chest Surg Clin N Am 2002; 12: 1-13
15. Goetze JP, Paloheimo LI, Linnala A, Sipponen P, Hanssen CP, Rehfeld JF. Gastrin-17 specific antibodies are too specific for gastrinoma but stain G-cells. Scand J Gastroenterol 2005; 40: 596-598
16. Mulholland G, Ardill JE, Fillmore D, Chittajallu RS, Fullarton GM, McColl KE. Helicobacter pylori related hypergastrinaemia is the result of a selective increase in gastrin 17. Gut 1993; 34: 757-761
17. Beardshall K, Moss S, Gill J, Levi S, Ghosh P, Playford RJ, Calam J. Suppression of Helicobacter pylori reduces gastrin releasing peptide stimulated gastrin release in duodenal ulcer patients. Gut 1992; 33: 601-603
18. Laheij RJ, Van Rossum LG, De Boer WA, Jansen JB. Corpus gastritis in patients with endoscopic diagnosis of reflux oesophagitis and Barrett's oesophagus. Aliment Pharmacol Ther 2002; 16: 887-891
19. Collen MJ, Johnson DA. Correlation between basal acid output and daily ranitidine dose required for therapy in Barrett's esophagus. Dig Dis Sci 1992; 37: 570-576
20. Mulholland MW, Reid BJ, Levine DS, Rubin CE. Elevated gastric acid secretion in patients with Barrett's metaplastic epithelium. Dig Dis Sci 1989; 34: 1329-1334
21. Haigh CR, Attwood SE, Thompson DG, Jankowski JA, Kirton CM, Pritchard DM, Varro A, Dimaline R. Gastrin induces proliferation in Barrett's metaplasia through activation of the CCK2 receptor. Gastroenterology 2003; 124: 615-625
22. Straathof JW, Lamers CB, Masclee AA. Effect of gastrin-17 on lower esophageal sphincter chracteristics in man. Dig Dis Sci 1997; 42: 2547-2551
23. Sipponen P, Ranta P, Helske T. Kääriäinen I, Mäki T, Linnala A, Suovaniemi O, Alanko A, Härkönen M. Serum level of amidated gastrin-17 and pepsinogen I in atrophic gastritis; an observational case-control study. Scand J Gastroenterol 2002; 37: 785-791
24. Väänänen H, Vauhkonen M, Helske T, Kääriäinen I, Rasmussen M, Tunturi-Hihnala H, Koskenpato J, Sotka M, Turunen M, Sandström R, Ristikankare M, Jussila A, Sipponen P. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and blood levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol 2003; 15: 885-891
25. Rehfeld JF, Christiansen LA, Malmström J, Schwartz T, Stadil F. The heterogeneity of gastrin, with reference to conversion of gastrin-17. Clin Endocrinol 1976: 5(Suppl): 185S-193S